Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): Possible role in hypersensitivity reactions

Asher Chanan-Khan, J. Szebeni, S. Savay, L. Liebes, N. M. Rafique, C. R. Alving, F. M. Muggia

Research output: Contribution to journal › Article › peer-review

322 Scopus citations

Fingerprint

Dive into the research topics of 'Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): Possible role in hypersensitivity reactions'. Together they form a unique fingerprint.

Medicine & Life Sciences